Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

675
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
675
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

598
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
598
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

13
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
13

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Violation detection in power operation sites based on multi-scale detection and few-shot learning.

Frontiers in artificial intelligence·2026
Same author

Interpreting the Economic Value of TPEx in Recurrent or Metastatic HNSCC: The Importance of Decision Context, Utility Timing, and Treatment Burden.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Association between Impaired Lung Function and Pulmonary Perfusion Defects Assessed by Phase-resolved Functional Lung MRI.

Radiology. Cardiothoracic imaging·2026
Same author

Beyond the Base Case: Payment Perspective and Ductal Carcinoma In Situ Management Assumptions in Artificial-Intelligence-Assisted Breast Screening Models.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Potential factors influencing quality of life in Chinese adult women with urinary incontinence: a nationwide cross-sectional study.

World journal of urology·2026
Same author

Machine learning and SHAP interpretation for predicting coronary heart disease-diabetes comorbidity with dietary antioxidants.

Scientific reports·2026

相关实验视频

Updated: Jul 11, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K

通过心脏收缩性调节来增强心肌功能:潜在的潜力和挑战

Zihan Li1,2, Qiming Liu1, Shenghua Zhou1

  • 1Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, China.

ESC heart failure
|November 10, 2023
PubMed
概括
此摘要是机器生成的。

心脏收缩性调制 (CCM) 是针对特定患者的新型心力衰竭治疗方法. 需要进一步的研究来确认益处并扩大其在不同患者群体中的使用.

关键词:
调节心脏收缩能力的调节.心脏器件是指心脏器件.设备植入装置的植入方式心脏衰竭是因为心脏衰竭.

更多相关视频

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

2.1K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K

相关实验视频

Last Updated: Jul 11, 2025

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.5K
Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes
09:17

Measurement of Heart Contractility in Isolated Adult Human Primary Cardiomyocytes

Published on: August 9, 2022

2.1K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

7.6K

科学领域:

  • 心脏病学 心脏病学
  • 生物医学工程 生物医学工程
  • 心脏衰竭管理的管理

背景情况:

  • 心脏收缩性调制 (CCM) 为心力衰竭 (HF) 患者提供了一个新的治疗选择.
  • 对于在特定的QRS持续时间标准内对心脏再同步治疗 (CRT) 无反应的个人来说,CCM特别重要.
  • 现有的研究主要集中在左心室效应上,在了解CCM对其他患者子组的影响方面存在差距.

研究的目的:

  • 审查CCM的机制基础.
  • 评估CCM对心肌功能的影响及其在各种患者群体中的适用性.
  • 确定CCM疗法未来研究的局限性和领域.

主要方法:

  • 对心脏收缩性调节现有研究的文献综述.
  • 分析CCM对心肌功能和患者结果的影响.
  • 识别知识缺口和未来的研究方向.

主要成果:

  • CCM显示出作为特定心力衰竭人群的治疗策略的潜力.
  • 目前,关于CCM对死亡率和住院率的影响的数据不足.
  • 植入CCM装置需要专业技能,对左心室效应的研究占据主导地位.

结论:

  • CCM为心力衰竭治疗提供了一个有前途的途径,但需要进一步研究.
  • 未来的研究应侧重于死亡率/住院益处,组合疗法,以及心房动对植入物的影响.
  • 扩大研究范围可以改进CCM的结果并扩大其对患者的适用性.